News | Virtual and Augmented Reality | January 20, 2023

Realize Medical Receives FDA Clearance For Virtual Reality Surgical Planning Software

Healthcare software start-up, Realize Medical, announced today that its virtual reality (VR) software for surgical planning, Elucis, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

January 20, 2023 — Healthcare software start-up, Realize Medical, announced today that its virtual reality (VR) software for surgical planning, Elucis (ee-loo-sis), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). 

“As one of the younRealgest companies in the mixed reality space, FDA clearance is a significant milestone – allowing us to transform our advanced and leading VR software into real benefits for physicians and their patients.” 

Elucis enables medical professionals to quickly create, understand, and share complex patient anatomy from CTs and MRIs in an immersive 3D environment. The one-of-a-kind virtual collaboration tool lets users connect with other users in a fully functional virtual reality environment from within VR or through desktop PCs. The platform can be used to improve 3D pre-operative planning and patient consultations. 

“Virtual planning with Elucis allows me to conceptualize innovative procedures with the end product of successful cases, development of new devices, and improved education for patients and families,” said Jenny Zablah MD, Congenital Interventional Cardiologist, Colorado. 

Current and planned use cases for Elucis are expected to align to the needs of surgeons across all disciplines. 

“We’re often told that Elucis represents the most advanced offering in the mixed reality space. But with powerful image processing, modeling, and collaboration tools, it’s also a comprehensive and complete platform for serving the full suite of growing 3D needs in medicine. With FDA clearance, we’re truly excited to enable an expanding era of procedure planning and collaboration.” – Justin Sutherland, CEO 

For more information: www.realizemed.com


Related Content

News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
News | Computed Tomography (CT)

September 29, 2023 —Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

Home September 29, 2023
Home
News | Computed Tomography (CT)

September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

Home September 19, 2023
Home
News | Computed Tomography (CT)

July 20, 2023 — A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical ...

Home July 20, 2023
Home
News | Computed Tomography (CT)

June 27, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) has released an expert consensus document ...

Home June 27, 2023
Home
Subscribe Now